Bracing for a Surge in Prostate Cancer Diagnoses Report: Demographic changes will lead to a doubling of cases, 85% increase in mortality by 2040 Apr 05, 2024
Some Cancer Patients Can Find It Hard to Tell Family and Friends Recent high-profile examples highlight this reluctance Mar 31, 2024
Mutation Linked to Increased Risk of Prostate Cancer Mortality Cancer-specific mortality twice as high in patients with specific genotype for HSD3B1 allele Mar 20, 2024
Getting Prostate Cancer Drugs Sooner; Limiting Toxic Emissions; FTC Sues 'Charity' News, features, and commentary about cancer-related issues Mar 14, 2024
Study Tests Office-Based Transperineal Approach to Prostate Biopsies Antibiotic-free option resulted in zero infections in randomized trial Feb 29, 2024 video
Another COVID Toll: Over 134,000 Undiagnosed Cancers During Height of Pandemic Diagnosis rates remained low throughout 2020, with mortality increase projected Feb 22, 2024
Cabozantinib Plus Atezolizumab Improves PFS in Metastatic CRPC A non-hormonal therapy control arm is appropriate in trials, says Neeraj Agarwal, MD Feb 22, 2024 video
Radioligand Therapy Continues to Show Promise for Metastatic CRPC Median OS of 15.5 months, PFS of 7.9 months with Ac-225-PSMA in heavily treated patients Feb 16, 2024
More Data Support Olaparib-Abiraterone in BRCA-Mutant Prostate Cancer BRCAAway trial confirms role of combination in first-line setting Feb 15, 2024 video
Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer News, features, and commentary about cancer-related issues Feb 02, 2024
Improved Fitness May Reduce Prostate Cancer Risk Observational study finds reduced incidence in men who increased their cardiorespiratory fitness Feb 01, 2024
Some 'Choosing Wisely' Recs Protect Older Folks From Low-Value Care Study looked at how three recommendations changed primary care decisions Jan 29, 2024
More Evidence That ARSIs for Prostate Cancer Differ in Cognitive Effects More fatigue, depression, worse reaction time with enzalutamide as compared with abiraterone Jan 29, 2024
Another Prostate Cancer Screening Candidate Outperforms Standard PSA Testing Multiparametric Stockholm3 avoided far more unnecessary biopsies without sacrificing sensitivity Jan 28, 2024
Cabozantinib Plus Atezolizumab Delays Progression in mCRPC Combination improved PFS versus more hormonal therapy, but control arm questioned Jan 26, 2024
No Cervical Cancer After HPV Vax; Brain Tumor Blood Test; Weight Loss and Cancer News, features, and commentary about cancer-related issues Jan 26, 2024
Olaparib-Abiraterone in Biomarker-Selected mCRPC Tops Each Agent Alone In small first-line trial, PFS more than doubled with combination Jan 26, 2024
Study Supports High-Dose RT, Long-Term ADT as Standard for High-Risk Prostate Cancer OS, PFS, cancer-specific survival all improved, with no increase in toxicity Jan 26, 2024
Apalutamide Makes Its Case in Biochemically Recurrent Nonmetastatic Prostate Cancer Intensification should be considered for high-risk patients, researchers say Jan 24, 2024
Two Million Cancers; Casgevy OK'd for Thalassemia; Rectal Exams and Prostate Cancer News, features, and commentary about cancer-related issues Jan 19, 2024
I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet But opening up can help reduce stigma and inform the public Jan 18, 2024
Surgeon Dies in Plane Crash; Austin Released From Hospital; Animal Pandemic Spreads Health news and commentary from around the Web gathered by staff Jan 16, 2024
Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA News, features, and commentary about cancer-related issues Jan 12, 2024
No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy No effect on anxiety but significantly less patient-rated pain Jan 12, 2024
Trump-Era Conscience Rule Rescinded; Lloyd Austin's Cancer; Sinead O'Connor's Death Health news and commentary from around the Web gathered by staff Jan 10, 2024
More Evidence Linking ADT for Prostate Cancer to Adverse Neurocognitive Effects Meta-analysis shows increased risk of dementia, Parkinson's, depression Jan 09, 2024
Language Minimizing Adverse Events; HPV and Thyroid Cancer; Ultrasound Bras News, features, and commentary about cancer-related issues Jan 05, 2024
Another CAR-T Warning; 'Sweet' Cancer Test; 'Molecular Jackhammer' Blows Up Cancer News, features, and commentary about cancer-related issues Dec 28, 2023
Testosterone for Hypogonadism Cleared So Far of Prostate Cancer Risk No excess high-grade or overall prostate cancer risk in TRAVERSE with 33 months of follow-up Dec 27, 2023
Mammo Responsibility Ups Screening; Opioids for Cancer Pain? Ignored Signs of CRC News, features, and commentary about cancer-related issues Dec 21, 2023
Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug News, features, and commentary about cancer-related issues Dec 07, 2023
TULSA Effective in Controlling Prostate Cancer Long-Term At 5 years, median PSA was reduced by 90% Dec 05, 2023
Let's Talk Drug Prices; Restoring the Sense of Touch; Learning From Tumors in a Dish News, features, and commentary about cancer-related issues Dec 01, 2023
Diagnostic Imaging Not Yet Enough for Biopsy-Free Radical Prostatectomy Study validates concerns about benign prostatic hyperplasia-related PSMA-PET false positives Nov 27, 2023
Reprogramming Tumors; Bad Stool Samples; Human Experiences in Cancer Care News, features, and commentary about cancer-related issues Nov 17, 2023
Vitamin D for Neuropathy; Good & Bad News for CAR-T; New Labeling for Surgical Mesh News, features, and commentary about cancer-related issues Nov 10, 2023
Moving Beyond the 'Angelina Jolie Effect' to Address Cancer Disparities A "local heroes effect" can better reach communities of color Nov 09, 2023
Wearables as Cancer Monitors; No China Price Break; Cancer Mystery in Appalachia News, features, and commentary about cancer-related issues Nov 03, 2023
Transitioning Cancer Survivors Away From Oncologic Care It's time for a new model of care Nov 03, 2023
Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPC Grade 3 or higher neutropenia, neutropenic complications reduced by 12-fold Nov 01, 2023
